Nafasy.AI

Patented sound AI technology that screens for respiratory diseases in seconds

Nafasy.AI is a health-tech company advancing a patented, smartphone-based AI tool that detects respiratory diseases from cough sounds in minutes, at zero cost to the user. Co-developed by Virufy and the University of Washington, the technology has achieved 84% sensitivity and specificity, backed by a proprietary dataset of 256,600 patient cough and speech samples paired with PCR results. Targeting a global burden of 15 billion respiratory infections a year, which is worsened in MENA and developing regions by poor air quality, dust, mass gatherings like Hajj, and dense transit hubs, Nafasy.AI requires no equipment, clinical setting, or trained personnel. Validated through a U.S. Department of Health BARDA contract, it is positioned to become a leading platform for accessible, early respiratory disease detection wherever there is a smartphone.

At A Glance

Geography

Dubai,UAE

San Fransisco, USA

Tokyo, Japan

Markets

Digital Health & AI Diagnostics

Business Model

B2B/B2G licensing for real-time disease surveillance

Revenue/sustainability model beyond grants and clinical partnerships

Stage

Seed

AI-powered respiratory screening from a smartphone cough

AI analysis of cough and breathing sounds, recorded on any smartphone, screens for patterns associated with respiratory disease — no lab equipment required. Lead product: AI cough/breath-based respiratory pre-screening tool.

1 billion

Potential to reach up to 1 billion people across developing nations

200

Nearly 200 patients enrolled in a Dubai Health pilot clinical study

Milestones & Awards

Showcased at Abu Dhabi Global Health Week 2025

Nafasy.AI showcased AI-powered respiratory screening technology at Abu Dhabi Global Health Week.

Learn more

Leadership

Amil Khanzada

Founder & CEO

Amil Khanzada

Founder & CEO

Amil Khanzada is a computer scientist, entrepreneur, and PhD candidate at the University of Fukui, Japan. He graduated in the top 5% of his class in Computer Science at UC Berkeley and pursued graduate work in AI and business at Berkeley and Stanford. When the pandemic hit in 2020, he founded Virufy, orchestrating clinical studies and building a global AI research team. He secured a US Department of Health (BARDA) contract, spoke at LEAP 2025, and is a delegate of One Young World.

Prof. Les Atlas

Chief Technology Officer

Prof. Les Atlas

Chief Technology Officer

Prof. Les Atlas holds a PhD in Electrical Engineering from Stanford University and is a professor of audio signal processing at the University of Washington. He brings decades of expertise in acoustic signal analysis and machine learning to Nafasy's core technology, overseeing the development of the patented AI algorithms that extract disease-specific patterns from cough audio samples.

About

Summit

Venture Building

Innovation Services

Partners